Omada Health Statistics
Total Valuation
Omada Health has a market cap or net worth of $972.58 million. The enterprise value is $770.32 million.
Important Dates
The last earnings date was Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Omada Health has 59.45 million shares outstanding. The number of shares has increased by 523.54% in one year.
| Current Share Class | 59.45M |
| Shares Outstanding | 59.45M |
| Shares Change (YoY) | +523.54% |
| Shares Change (QoQ) | -7.83% |
| Owned by Insiders (%) | 2.95% |
| Owned by Institutions (%) | 67.05% |
| Float | 46.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 50.02 |
| PS Ratio | 3.47 |
| Forward PS | 2.87 |
| PB Ratio | 4.18 |
| P/TBV Ratio | 4.49 |
| P/FCF Ratio | 45.78 |
| P/OCF Ratio | 43.58 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.72 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 35.91 |
Financial Position
The company has a current ratio of 3.92
| Current Ratio | 3.92 |
| Quick Ratio | 3.69 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.65 |
Financial Efficiency
Return on equity (ROE) is -4.30% and return on invested capital (ROIC) is -3.23%.
| Return on Equity (ROE) | -4.30% |
| Return on Assets (ROA) | -2.35% |
| Return on Invested Capital (ROIC) | -3.23% |
| Return on Capital Employed (ROCE) | -3.57% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $300,419 |
| Profits Per Employee | -$6,681 |
| Employee Count | 943 |
| Asset Turnover | 1.28 |
| Inventory Turnover | 27.81 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 14.17 |
| 200-Day Moving Average | 17.59 |
| Relative Strength Index (RSI) | 60.35 |
| Average Volume (20 Days) | 1,204,149 |
Short Selling Information
The latest short interest is 4.22 million, so 7.10% of the outstanding shares have been sold short.
| Short Interest | 4.22M |
| Short Previous Month | 3.66M |
| Short % of Shares Out | 7.10% |
| Short % of Float | 9.05% |
| Short Ratio (days to cover) | 5.68 |
Income Statement
In the last 12 months, Omada Health had revenue of $283.30 million and -$6.30 million in losses. Loss per share was -$0.13.
| Revenue | 283.30M |
| Gross Profit | 187.73M |
| Operating Income | -8.36M |
| Pretax Income | -6.30M |
| Net Income | -6.30M |
| EBITDA | -2.69M |
| EBIT | -8.36M |
| Loss Per Share | -$0.13 |
Full Income StatementBalance Sheet
The company has $211.77 million in cash and n/a in debt, with a net cash position of $211.77 million or $3.56 per share.
| Cash & Cash Equivalents | 211.77M |
| Total Debt | n/a |
| Net Cash | 211.77M |
| Net Cash Per Share | $3.56 |
| Equity (Book Value) | 234.12M |
| Book Value Per Share | 3.95 |
| Working Capital | 200.75M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $22.54 million and capital expenditures -$1.09 million, giving a free cash flow of $21.45 million.
| Operating Cash Flow | 22.54M |
| Capital Expenditures | -1.09M |
| Depreciation & Amortization | 5.67M |
| Net Borrowing | -30.96M |
| Free Cash Flow | 21.45M |
| FCF Per Share | $0.36 |
Full Cash Flow StatementMargins
Gross margin is 66.27%, with operating and profit margins of -2.95% and -2.22%.
| Gross Margin | 66.27% |
| Operating Margin | -2.95% |
| Pretax Margin | -2.22% |
| Profit Margin | -2.22% |
| EBITDA Margin | -0.95% |
| EBIT Margin | -2.95% |
| FCF Margin | 7.57% |
Dividends & Yields
Omada Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -523.54% |
| Shareholder Yield | -523.54% |
| Earnings Yield | -0.64% |
| FCF Yield | 2.18% |
Analyst Forecast
The average price target for Omada Health is $23.00, which is 40.59% higher than the current price. The consensus rating is "Buy".
| Price Target | $23.00 |
| Price Target Difference | 40.59% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 17.73% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Omada Health has an Altman Z-Score of 8.67 and a Piotroski F-Score of 4.
| Altman Z-Score | 8.67 |
| Piotroski F-Score | 4 |
